文献速递儿童感染儿童消化与营养

西安儿童侵袭性非伤寒沙门菌感染临床特征与耐药分析

[Clinical features and antimicrobial resistance analysis of invasive non-typhoid Salmonella infection in children at Xi'an].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2026-01-01

该回顾性队列研究分析了2019年至2024年西安儿童医院51例经无菌体液或手术深部脓液培养确诊的侵袭性非伤寒沙门菌感染患儿,发现主要发生于3岁以下婴幼儿,以发热、腹痛、腹泻为主,血清型以D群肠炎沙门菌为主,推荐第三代头孢菌素作为经验性抗感染治疗药物。

要点

  • 侵袭性非伤寒沙门菌感染主要发生于3岁以下婴幼儿,4至10月为发病高峰。
  • 血清型以D群肠炎沙门菌为主,占41%。
  • 哌拉西林他唑巴坦、厄他培南和亚胺培南敏感率均为100%,推荐第三代头孢菌素经验性治疗。

核心结论

  • 西安地区儿童侵袭性非伤寒沙门菌感染主要发生于3岁以下婴幼儿,主要表现为发热、腹痛、腹泻,血清型以D群肠炎沙门菌为主,推荐第三代头孢菌素作为经验性抗感染治疗药物。

研究设计与样本

  • 回顾性队列研究,纳入2019年1月至2024年12月西安市儿童医院感染科、普通外科和骨科收治的经无菌体液或手术深部脓液培养确诊的51例侵袭性非伤寒沙门菌感染患儿。
  • 根据侵袭部位分为血流感染组和局部感染组,采用Mann-Whitney U检验和χ2检验对两组炎症指标、血清型分布及耐药性差异进行分析。

主要发现

  • 51例患儿中男27例、女24例,就诊年龄19(14,40)月龄;<1岁9例(17%),1~<3岁28例(55%),≥3~6岁7例(14%),≥6岁7例(14%)。
  • 4~10月份发病44例(86%);血流感染组41例,局部感染组10例(骨髓炎6例、阑尾炎伴腹膜炎2例、肛周或腹腔脓肿2例)。
  • 发热45例(88%),腹泻、腹痛22例(43%),恶心、呕吐11例(22%),肠系膜淋巴结肿大4例(8%);治愈31例(61%)、好转20例(39%)。
  • 局部感染组白细胞计数高于血流感染组(P<0.05)。
  • 血清型主要为D群肠炎沙门菌21例(41%)、C群10例(20%)、B群10例(20%)。

关键数值与推荐

  • 对哌拉西林他唑巴坦、厄他培南和亚胺培南的敏感率均为100%(51/51)。
  • 对头孢他啶、头孢曲松、头孢吡肟的敏感率分别为80%(41/51)、80%(41/51)、86%(44/51)。
  • 对复方新诺明、氨曲南、氨苄西林、氨苄西林舒巴坦和环丙沙星的耐药(含中介)率分别为24%(12/51)、16%(8/51)、57%(29/51)、57%(29/51)和75%(38/51)。
  • 血流感染组与局部感染组对头孢他啶、头孢曲松、头孢吡肟、复方新诺明、氨苄西林、氨苄西林舒巴坦、氨曲南和环丙沙星的耐药(含中介)率差异均无统计学意义(均P>0.05)。

临床怎么用

  • 对3岁以下婴幼儿出现发热、腹痛、腹泻,尤其在4至10月份,应警惕侵袭性非伤寒沙门菌感染。
  • 根据耐药性结果,推荐第三代头孢菌素作为儿童侵袭性非伤寒沙门菌感染的经验性抗感染治疗药物。

局限性

  • 本研究为单中心回顾性队列研究,样本量51例,可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical characteristics, serogroups and antimicrobial resistance of invasive non-typhoid Salmonella infection in children at Xi'an area. Methods: Retrospective cohort study. The clinical manifestations, treatment, prognosis, serogroups and antimicrobial drug resistance of 51 hospitalized children with invasive non-typhoid Salmonella infection confirmed by sterile body fluids or deep pus culture after operation at the Department of Infectious Diseases, the Department of General Surgery and the Department of Orthopedics in Xi'an Children's Hospital from January 2019 to December 2024 were retrospectively analyzed. The patients were divided into bloodstream infection group and local infection group according to the invasion site. The inflammatory markers, serogroups distribution and antimicrobial resistance were analyzed statistically by using Mann-Whitney U test and χ2 test. Results: Among the 51 children, there were 27 males and 24 females, with an onset age of 19 (14, 40) months. Nine cases (17%) were <1 year old, 28 cases (55%) under 1 - <3 years old, 7 cases (14%) under 3-<6 years old and 7 cases (14%) ≥ 6 years old. The onset time of 44 cases (86%) was from April to October. The diseases included 41 cases of bloodstream infection group, 10 cases of local infection group(including 6 cases of osteomyelitis involving the hip joint or humerus or pubis or navicular bone, 2 case of appendicitis with peritonitis and 2 cases of perianal or intra-abdominal abscess). The clinical manifestations were fever in 45 cases(88%), diarrhea and abdominal pain in 22 cases (43%), nausea and vomiting in 11 cases (22%), mesenteric lymphadenopathy in 4 cases (8%). Thirty-one cases (61%) were cured and twenty cases (39%) were improved by effective antibiotics treatment. White blood cell count in local infection group was significantly higher than that in bloodstream infection group (P<0.05).The serogroups of D (Salmonella enteritidis), C and B were the most prevalent among non-typhoid Salmonella isolates, accounting for 21 cases (41%), 10 cases (20%) and 10 cases (20%) respectively. Antibacterial drug sensitivity test showed that the sensitivity rates of piperaciratazobactam, ertapenem and imipenem all were 100% (51/51), those of ceftazidime, ceftriaxone and cefepime were 80% (41/51), 80% (41/51) and 86% (44/51), respectively. The drug resistance(including intermediate) rates of trimethoprim-sulfamethoxazole, aztreonam, ampicillin, ampicillin-sulbactam and ciprofloxacin were 24% (12/51), 16% (8/51), 57% (29/51), 57% (29/51) and 75% (38/51), respectively. There were no statistical differences in the drug resistance (including intermediate) rates of ceftazidime, ceftriaxone, cefepime, trimethoprim-sulfamethoxazole, ampicillin, ampicillin-sulbactam, aztreonam and ciprofloxacin between the bloodstream infection group and local infection group (all P>0.05). Conclusions: Invasive non-typhoid Salmonella infection in children at Xi'an area mainly occurred in infants younger than 3 years old. The main clinical manifestations are fever, abdominal pain and diarrhea.The serotypes are predominantly group D (Salmonella enteritidis). The third generation of cephalosporins is recommended as the drugs for empirical antibiotics treatment according to antimicrobial resistance and pediatric population. 目的: 探讨西安地区儿童侵袭性非伤寒沙门菌感染的临床特征、血清型及抗生素药物耐药性。 方法: 回顾性队列研究。分析2019年1月至2024年12月西安市儿童医院感染科、普通外科和骨科收治的经无菌体液或手术深部脓液培养确诊的51例侵袭性非伤寒沙门菌感染患儿的临床表现、治疗、预后、血清型及抗生素药物耐药性等资料。根据侵袭部位分为血流感染组和局部感染组,采用Mann-Whitney U和χ2检验对两组患儿的炎症指标、血清型分布及药物耐药性差异进行分析。 结果: 51例患儿中,男27例、女24例,就诊年龄19(14,40)月龄。<1岁9例(17%)、1~<3岁28例(55%)、≥3~6岁7例(14%)、≥6岁7例(14%)。4~10月份发病44例(86%)。血流感染组41例、局部感染组10例(髋关节或肱骨或耻骨或舟骨骨髓炎6例、阑尾炎伴腹膜炎2例、肛周或腹腔脓肿2例)。发热45例(88%),腹泻、腹痛22例(43%),恶心、呕吐11例(22%),肠系膜淋巴结肿大4例(8%)。经有效抗菌药物治疗,治愈31例(61%)、好转20例(39%)。局部感染组白细胞计数高于血流感染组(P<0.05)。非伤寒沙门菌血清型主要为D群肠炎沙门菌21例(41%)、C群10例(20%)、B群10例(20%)。抗生素药物敏感性试验显示对哌拉西林他唑巴坦、厄他培南和亚胺培南的敏感率均为100%(51/51),头孢他啶、头孢曲松、头孢吡肟的敏感率分别为80%(41/51)、80%(41/51)、86%(44/51),复方新诺明、氨曲南、氨苄西林、氨苄西林舒巴坦和环丙沙星的耐药(含中介)率分别为24%(12/51)、16%(8/51)、57%(29/51)、57%(29/51)和75%(38/51)。血流感染组与局部感染组对头孢他啶、头孢曲松、头孢吡肟、复方新诺明、氨苄西林、氨苄西林舒巴坦、氨曲南和环丙沙星的耐药(含中介)率差异均无统计学意义(均P>0.05)。 结论: 西安地区儿童侵袭性非伤寒沙门菌感染主要发生于3岁以下婴幼儿,主要表现为发热、腹痛、腹泻,血清型以D群肠炎沙门菌为主。根据抗生素药物耐药性和儿童群体特性,推荐第三代头孢菌素作为经验性抗感染治疗药物。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Shi JF, Tang JY, Li RN, et al. [Clinical features and antimicrobial resistance analysis of invasive non-typhoid Salmonella infection in children at Xi'an]. Zhonghua Er Ke Za Zhi. 2026. PMID: 42527132. doi:10.3760/cma.j.cn112140-20260316-00212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。